overwiew_ Pharm: NSG6005

overwiew_ Pharm: NSG6005 WEEK 1 Discussion Question Response: By the due date assigned, post your response to one of the discussion questions in the appropriate thread in the Discussion Area Participation Responses: No later than the end of the week, review and comment on the discussion questions responses posted by at least two of your peers. Guidelines: Support your responses with scholarly academic references using APA style format. Assigned course reading and online library resources are preferred. Weekly lecture notes are designed as overviews to the topic for the respective week and should not serve as a citation or reference. In your discussion question response, provide a substantive response that illustrates a well-reasoned and thoughtful response; is factually correct with relevant scholarly citations, references, and examples; demonstrates a clear connection to the readings In your participation responses to your peers, comments must demonstrate thorough analysis of postings and extend meaningful discussion by building on previous postings. Note: Review South University's Substantive Participation Policy Criteria, Helpful Tips, and Late Policy available by clicking on the South University Policy and Guidelines navigation tab. The late policy applies to late discussion question responses. Discussion Question 1 For this questions, please read the following case study and then respond to the questions noted below. Ms. BD is a 33-year-old G2P1 female who has a history of chronic HTN. She was diagnosed with this in the interim since her first pregnancy, and she has been well controlled with Prinizide 12.5/20 PO BID. Her period, usually very regular, was 5 days late. She performed a home pregnancy test which was positive. She states she feel "OK" but is concerned about both her HTN and her developing fetus. She has no other medical problems, symptoms, or concerns. Assessment: Physical examination is unremarkable. Her BP is 128/68 and her pulse is 74. Her urine human chorionic gonadotropin (HCG) is positive. Her potassium is 4.2, blood urea nitrogen (BUN) is 14, and creatinine is 0.6. Alanine aminotransferase (ALT) is 29. White blood cells (WBCs) are 6.5, hemoglobin (Hgb) is 12.8, hematocrit (Hct) is 39, and platelets are 330,000. 1. Is there any additional subjective or objective information you need for this client? Explain. 2. Is Prinizide safe in pregnancy? What are the possible complications to the pregnant woman and her fetus? 3. Why is it important to assess the above laboratory values? How might this information impact your treatment plan? 4. Would you make any changes to Ms. BD’s blood pressure medications? Explain. If yes, what would you prescribe? Discuss the medications safety in pregnancy, mechanism of action, route, the half-life; how it is metabolized in and eliminated from the body; and contraindications and black box warnings. 5. What health maintenance or preventive education is important for this client based on your choice medication/treatment? 6. Would you treat this patient or refer her? Where would you refer this patient? WEEK 2 Discussion Question Response: By the due date assigned, post your response to one of the discussion questions in the appropriate thread in the Discussion Area ………………………………CONTINUED……………………………………